US 11542526
Oncolytic adenoviral vector and methods of use
granted A61KA61K35/761A61K45/06
Quick answer
US patent 11542526 (Oncolytic adenoviral vector and methods of use) held by Unleash Immuno Oncolytics, Inc. expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Unleash Immuno Oncolytics, Inc.
- Grant date
- Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K35/761, A61K45/06, A61K48/00, A61P